Overview
Sumanta Pal is an Oncologist practicing medicine in Irvine, California.
Dr. Pal is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Bladder Cancer, Nephrectomy, and Lymphadenectomy.
He is actively involved in clinical research, co-authoring 677 peer reviewed articles and participating in 22 clinical trials.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Irvine, CA 92618
1500 Duarte Rd, Duarte, CA 91010
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
19 Clinical Trials
Tanya Siddiqi, M.D.
Tanya Siddiqi is an Oncologist practicing medicine in Irvine, California. Dr. Siddiqi is highly rated in 36 conditions, according to our data. Her clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
UCI Health Newport - Birch Street
Dr. Jaime Landman, director of the UCI HealthCenter for Urological Care, is an internationally recognized urologist and expert in diseases and conditions of the kidneys, including kidney stones and benign and malignant tumors. He is experienced in all forms of minimally invasive kidney surgery, including robot-assisted surgery and percutaneous cryoablation.Landman, who founded the UCI HealthAblative Oncology Center,has performed thousands of advanced minimally invasive kidney procedures. He is dedicated to improving the techniques and technology associated with minimally invasive surgery.The author of more than 185 peer-reviewed articles and more than 60 book chapters, Landman has lectured around the world on the subject of minimally invasive urology. His research interests are in kidney cancer outcomes, kidney ablation and kidney imaging technologies, as well as preserving kidney function.His research efforts have helped define many of the minimally invasive kidney procedures performed today, earning him the 2005 Arthur Smith prize for creativity and dynamic innovation at the World Congress of Endourology. His clinical interests include all aspects of minimally invasive urologic oncology, with special emphasis on kidney cancer and kidney stone disease. Dr. Landman is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Kidney Stones, Renal Cell Carcinoma (RCC), Ureterocele, Lithotripsy, and Nephrectomy. Dr. Landman is board certified in American Board Of Urology - Urology.
Alex Herrera, M.D.
Alex Herrera is an Oncologist practicing medicine in Duarte, California. He has been practicing medicine for over 17 years. Dr. Herrera is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Herrera is board certified in American Board Of Internal Medicine, Hematology and American Board Of Internal Medicine, Oncology.
Frequently Asked Questions about Dr. Sumanta Pal
How do I make an appointment with Dr. Sumanta Pal?
You can book an appointment with Dr. Sumanta Pal by calling their office at 847-342-6842. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Sumanta Pal a top-rated expert for Renal Cell Carcinoma (RCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sumanta Pal is classified as an Elite expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Sumanta Pal specialize in?
While Dr. Sumanta Pal is a Oncology, they have specific expertise in Renal Cell Carcinoma (RCC), Urothelial Cancer, and Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Sumanta Pal participate in research or clinical trials?
Yes. Dr. Sumanta Pal has published 674 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Dr. Sumanta Pal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Sumanta Pal accept my insurance?
Dr. Sumanta Pal accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 847-342-6842 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bladder CancerDr. Pal isElite. Learn about Bladder Cancer.
- Prostate CancerDr. Pal isElite. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)
- Urothelial CancerDr. Pal isElite. Learn about Urothelial Cancer.
- Distinguished
- Adult Soft Tissue SarcomaDr. Pal isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Chromophobe Renal Cell CarcinomaDr. Pal isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Pal isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Prostate CancerDr. Pal isDistinguished. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Pal isDistinguished. Learn about Familial Wilms Tumor 2.
- LymphadenectomyDr. Pal isDistinguished. Learn about Lymphadenectomy.
- Advanced
- Lung CancerDr. Pal isAdvanced. Learn about Lung Cancer.
- MelanomaDr. Pal isAdvanced. Learn about Melanoma.
- Metastatic Brain TumorDr. Pal isAdvanced. Learn about Metastatic Brain Tumor.
- Metastatic Pleural TumorDr. Pal isAdvanced. Learn about Metastatic Pleural Tumor.
- Penile CancerDr. Pal isAdvanced. Learn about Penile Cancer.
- PIK3CA-Related Overgrowth Spectrum
- Experienced
- Adrenal Insufficiency PediatricDr. Pal isExperienced. Learn about Adrenal Insufficiency Pediatric.
- AgranulocytosisDr. Pal isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Anal CancerDr. Pal isExperienced. Learn about Anal Cancer.
- Bone TumorDr. Pal isExperienced. Learn about Bone Tumor.
- Brain TumorDr. Pal isExperienced. Learn about Brain Tumor.